Table 3. The subgroup analysis according to the type of clinic (endocrinology centers versus internal medicine centers).
| Variable | At baseline | At month 6 | ||||||
|---|---|---|---|---|---|---|---|---|
| Total (n=8,636) |
Endocrinology (n=4,380) |
Others (n=4,256) |
P value | Total (n=8,636) |
Endocrinology (n=4,380) |
Others (n=4,256) |
P value | |
| HbA1c, % | 9.2±1.4 | 9.3±1.5 | 9.1±1.3 | <0.0001 | 7.4±1.1 | 7.6±1.2 | 7.2±0.8 | <0.0001a |
| HbA1c, <7.0% | - | - | - | - | 4,793 (55.5) | 2,618 (59.8) | 2,175 (51.1) | <0.0001a |
| Body weight, kg | 65.2±10.3 | 64.5±10.6 | 65.9±9.9 | <0.0001 | 65.5±10.1 | 65.1±10.4 | 66.0±9.7 | <0.0001a |
| Insulin dose, IU | 16.9±7.9 | 16.3±7.4 | 17.6±8.2 | <0.0001 | 24.5±9.3 | 24.6±10.4 | 24.4±8.0 | <0.0001a |
| Duration of diabetes, yr | 8.9±5.9 | 9.1±6.2 | 8.7±5.6 | 0.0028 | - | - | - | - |
Values are presented as mean±standard deviation or the number (%).
HbA1c, glycosylated hemoglobin; IU, international unit.
aAnalysis of covariance (covariates: baseline value).